IL96714A0 - Antibody antagonists of human interleukin-4 - Google Patents

Antibody antagonists of human interleukin-4

Info

Publication number
IL96714A0
IL96714A0 IL96714A IL9671490A IL96714A0 IL 96714 A0 IL96714 A0 IL 96714A0 IL 96714 A IL96714 A IL 96714A IL 9671490 A IL9671490 A IL 9671490A IL 96714 A0 IL96714 A0 IL 96714A0
Authority
IL
Israel
Prior art keywords
binding
antagonists
antibody antagonists
receptors
human interleukin
Prior art date
Application number
IL96714A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL96714A0 publication Critical patent/IL96714A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL96714A 1989-12-20 1990-12-18 Antibody antagonists of human interleukin-4 IL96714A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45357089A 1989-12-20 1989-12-20

Publications (1)

Publication Number Publication Date
IL96714A0 true IL96714A0 (en) 1991-09-16

Family

ID=23801108

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96714A IL96714A0 (en) 1989-12-20 1990-12-18 Antibody antagonists of human interleukin-4

Country Status (26)

Country Link
US (1) US6358509B1 (xx)
EP (1) EP0506826B1 (xx)
JP (1) JPH0730116B2 (xx)
KR (1) KR960016862B1 (xx)
AT (1) ATE136906T1 (xx)
AU (1) AU639754B2 (xx)
CA (1) CA2071908C (xx)
CZ (1) CZ283050B6 (xx)
DE (1) DE69026627T2 (xx)
DK (1) DK0506826T3 (xx)
ES (1) ES2085983T3 (xx)
FI (1) FI104180B1 (xx)
GR (1) GR3020325T3 (xx)
HU (1) HU215245B (xx)
IE (1) IE74708B1 (xx)
IL (1) IL96714A0 (xx)
MX (1) MX9203401A (xx)
MY (1) MY106507A (xx)
NO (1) NO922457D0 (xx)
NZ (1) NZ236511A (xx)
OA (1) OA09704A (xx)
PT (1) PT96230B (xx)
SK (1) SK635290A3 (xx)
TW (1) TW221675B (xx)
WO (1) WO1991009059A1 (xx)
ZA (1) ZA9010190B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714146A (en) * 1992-08-26 1998-02-03 Board Of Regents Of The University Of Washington IL-4 bone therapy
ZA946765B (en) 1993-09-02 1996-02-15 Dartmouth College Methods of prolonged suppression of humoral immunity
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
BR9407575A (pt) * 1993-09-07 1996-07-16 Smithkline Beecham Corp Recombinaçao il4 de anticorpos uteis no tratamento de desordens do il4
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US5705154A (en) * 1995-03-08 1998-01-06 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
JP2001511187A (ja) * 1997-02-28 2001-08-07 エンゾー セラピュウティクス， インコーポレイテッド 選択的免疫ダウンレギュレーション（ｓｉｄｒ）を行う新規プロセス
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
CN104611339A (zh) 1998-12-14 2015-05-13 遗传研究所有限责任公司 细胞因子受体链
DE60135170D1 (de) * 2000-04-06 2008-09-18 Fujifilm Corp Farbstoffkomplex und optisches Informationsaufzeichnungsmedium
EP2292665B1 (en) 2000-05-26 2015-07-08 Immunex Corporation Use of interleukin-4 antibodies and compositions thereof
US20020076409A1 (en) * 2000-07-12 2002-06-20 March Carl J. Method for treating cancer
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
AU2003251633A1 (en) * 2002-07-01 2004-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Il-21 as a regulator of immunoglobin production
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
WO2004096849A2 (en) * 2003-04-25 2004-11-11 University Of Manitoba Peptide-based cytokine/chemokine vaccines against allergy
ATE548388T1 (de) 2003-11-07 2012-03-15 Immunex Corp An den interleukin-4-rezeptor bindende antikörper
HUE049161T2 (hu) 2003-12-23 2020-09-28 Genentech Inc Új anti-IL13 antitestek és alkalmazásaik
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
AR050044A1 (es) * 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
CN102216323B (zh) * 2008-11-17 2016-08-03 哥本哈根大学 用于调节慢性炎症反应和治疗自身免疫性疾病的源自il-4的肽
EP2560683B2 (en) 2010-04-23 2022-07-20 F. Hoffmann-La Roche AG Production of heteromultimeric proteins
US10689447B2 (en) 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
MX355255B (es) 2011-02-04 2018-04-11 Genentech Inc Variantes de fc y métodos para su producción.
MX2015013901A (es) * 2013-04-05 2015-12-11 Genentech Inc Anticuerpos anti-il-4 y anticuerpos biespecificos y sus usos.
SG10201802525QA (en) 2013-09-13 2018-04-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
BR112016004437A2 (pt) 2013-09-13 2017-10-17 Genentech Inc métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
CN106471117A (zh) 2014-05-06 2017-03-01 豪夫迈·罗氏有限公司 使用哺乳动物细胞产生异多聚体蛋白
RU2758092C1 (ru) * 2018-02-01 2021-10-26 Бэйцзин Кавин Текнолоджи Шеа-Холдинг Ко., Лтд. АНТИТЕЛО К IL-4Rα И ЕГО ПРИМЕНЕНИЕ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
ZA872781B (en) 1986-05-19 1987-10-05 Immunology Ventures B-cell stimulating factor
EP0397764A1 (en) * 1988-02-02 1990-11-22 Schering Biotech Corporation Method of reducing immunoglobulin e responses

Also Published As

Publication number Publication date
CA2071908A1 (en) 1991-06-21
FI104180B (fi) 1999-11-30
WO1991009059A1 (en) 1991-06-27
US6358509B1 (en) 2002-03-19
DE69026627D1 (de) 1996-05-23
NO922457L (no) 1992-06-19
MX9203401A (es) 1992-07-01
CZ283050B6 (cs) 1997-12-17
CA2071908C (en) 2002-04-30
MY106507A (en) 1995-06-30
IE904589A1 (en) 1991-07-03
IE74708B1 (en) 1997-07-30
GR3020325T3 (en) 1996-09-30
DE69026627T2 (de) 1996-08-22
DK0506826T3 (da) 1996-05-13
FI104180B1 (fi) 1999-11-30
FI922847A0 (fi) 1992-06-18
EP0506826A1 (en) 1992-10-07
ZA9010190B (en) 1991-08-28
SK279933B6 (sk) 1999-06-11
ATE136906T1 (de) 1996-05-15
SK635290A3 (en) 1999-06-11
AU639754B2 (en) 1993-08-05
NO922457D0 (no) 1992-06-19
AU7176291A (en) 1991-07-18
PT96230A (pt) 1991-10-15
KR960016862B1 (ko) 1996-12-23
HU215245B (hu) 1998-11-30
PT96230B (pt) 1998-06-30
CZ635290A3 (en) 1997-08-13
JPH04506359A (ja) 1992-11-05
JPH0730116B2 (ja) 1995-04-05
EP0506826B1 (en) 1996-04-17
HU9202073D0 (en) 1992-09-28
OA09704A (en) 1993-08-30
NZ236511A (en) 1993-02-25
TW221675B (xx) 1994-03-11
KR920703642A (ko) 1992-12-18
FI922847A (fi) 1992-06-18
HUT64568A (en) 1994-01-28
ES2085983T3 (es) 1996-06-16

Similar Documents

Publication Publication Date Title
GR3020325T3 (en) Antibody antagonists of human interleukin-4
AU4128089A (en) Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
DK0760857T5 (da) Receptor for onkostatin M
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
DE69232952D1 (de) Antikörper der Rezeptoren von pluripotenten hämatopoetischen Stammzellen flk-1
ES8607564A1 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
TW272197B (xx)
DE3867537D1 (de) Mischung von monoklonalen antikoerpern zur bestimmung der creatinkinaseaktivitaet.
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
ATE215598T1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
DE3884972D1 (de) Fibrinspezifischer Antikörper, Verfahren zu seiner Herstellung und seine Verwendung.
IT1220490B (it) Perfezionamento degli elementi che attrezzano il recipiente,adatto per impastare farina con altri ingredienti e per la cottura dell'impasto ottenuto
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin